All 1 tracked stories fall under one category: pharma. MGI Tech is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 2.8 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about DCS Lab
All 1 tracked stories fall under one category: pharma. MGI Tech is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 2.8 across the same-window beat baseline. At 6, the average consequence score sits below the same-window beat average of 6.4. DCS Lab appears in 1 tracked Biotech story from March 20, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering DCS Lab. Shared-story counts are live from our verified record — not editorial picks.
MGI Tech and the National University of Singapore (NUS) have announced a strategic collaboration to establish a DCS Lab focused on multi-omics innovation. The facility will leverage MGI's advanced sequencing technologies to accelerate drug discovery and pharmaceutical research in the APAC region.
DCS Lab is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.